Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADK | P55263 | 1/20 | 0.50 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.41 |
| ▸ | PYGB | P11216 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9805192 | 1.00 | ADK (0.50) | ADKADORA1PYGBTSHRMEN1 | |
| SCHEMBL29466237 | 1.00 | ADK (0.50) | ADKADORA1PYGBTSHRMEN1 | |
| SCHEMBL6039895 | 1.00 | ADK (0.50) | ADKADORA1PYGBTSHRMEN1 | |
| SCHEMBL9805157 | 0.85 | ADK (0.57) | ADKADORA1TSHRMEN1KMT2A | |
| SCHEMBL9805249 | 0.81 | ADK (0.51) | ADKADORA1TSHRMEN1KMT2A | |
| SCHEMBL9805237 | 0.81 | ADK (0.65) | ADKADORA1MEN1KMT2A | |
| SCHEMBL9805553 | 0.81 | ADK (0.65) | ADKADORA1MEN1KMT2A | |
| SCHEMBL9805185 | 0.81 | PI4KA (0.40) | ADKADORA1MEN1KMT2A | |
| SCHEMBL29062123 | 0.79 | ADK (0.47) | ADKADORA1 | |
| SCHEMBL30105884 | 0.79 | ADK (0.47) | ADKADORA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060078977-A1 | Novel purified polypeptides from Enterococcus faecalis | AFFINIUM PHARMACEUTICALS, INC. (CA) | 2006-04-13 | — | — | US | disclosed |
| US-5041542-A | Antitumor-anticarcinogenic agents | NUCLEIC ACID RESEARCH INSTITUTE (US) | 1991-08-20 | — | — | US | disclosed |